Bio-Path Holdings (BPTH)
(Delayed Data from NSDQ)
$1.10 USD
-0.09 (-7.56%)
Updated Oct 9, 2024 04:00 PM ET
After-Market: $1.00 -0.10 (-9.09%) 7:58 PM ET
4-Sell of 5 4
F Value A Growth B Momentum C VGM
Industry / Sector Report
Industry : Medical - Drugs
Zacks Industry Rank
Top 40% (100 out of 250)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.00 | 1.55 | 9.99 |
Current Quarter Estimate | -1.02 | 0.44 | 63.00 |
Year Ago Quarter Estimate | -6.40 | 0.11 | 52.25 |
Next Quarter Estimate | -1.01 | -1.66 | 66.00 |
Next Year Estimate | -4.04 | 13.59 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 81.56 | 19.40 | 15.67 |
Next Year | 34.84 | 16.90 | 11.34 |
Last 5 Years | NA | 7.70 | 8.10 |
Next 5 Years | NA | 21.20 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -2.64 |
Price/Book (MRQ) | 1.77 | 1.52 |
Price/Cash Flow (MRFY) | NA | 8.63 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | NA | -203.98% |
Return on Equity (TTM) | -2,842.40% | -81.98% |
Debt to Equity (MRQ) | NA | 0.64 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.